SynthesisFrontiers in immunology2025

First-line immune checkpoint inhibitors with chemotherapy in advanced gastric and gastroesophageal junction adenocarcinoma: a meta-analysis of phase 3 trials.

Yuxuan Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.